Literature DB >> 4263289

Pilo-sebaceous duct obstruction and acne.

R L Holmes, M Williams, W J Cunliffe.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4263289     DOI: 10.1111/j.1365-2133.1972.tb07418.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  Acne Lesion Extraction versus Oral Doxycycline for Moderate Acne Vulgaris: A Randomized Clinical Trial.

Authors:  Irma Bernadette S Sitohang; Retno W Soebaryo; Mpu Kanoko
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

2.  Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment.

Authors:  R Greenwood; L Brummitt; B Burke; W J Cunliffe
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-02

3.  Tetracycline and acne vulgaris: a clinical and laboratory investigation.

Authors:  W J Cunliffe; R A Forster; N D Greenwood; C Hetherington; K T Holland; R L Holmes; S Khan; C D Roberts; M Williams; B Williamson
Journal:  Br Med J       Date:  1973-11-10

4.  Efficacy of chlorhexidine gluconate ointment (Oronine H(®)) for experimentally-induced comedones.

Authors:  Takako Yamakoshi; Teruhiko Makino; Kenji Matsunaga; Yoko Yoshihisa; Mati Ur Rehman; Taisuke Seki; Yoshito Hayashi; Tadamichi Shimizu
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-07-09

5.  Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris.

Authors:  Howayda S Abd El All; Noha S Shoukry; Rabee A El Maged; Mostafa M Ayada
Journal:  Diagn Pathol       Date:  2007-01-30       Impact factor: 2.644

6.  Lipid Droplet Proteins in Acne Skin: A Sound Target for the Maintenance of Low Comedogenic Sebum and Acne-Prone Skin Health.

Authors:  Olivier Sorg; Thérèse Nocera; Fabienne Fontao; Nathalie Castex-Rizzi; Lucile Garidou; Christophe Lauze; Jimmy Le Digabel; Gwendal Josse; Jean-Hilaire Saurat
Journal:  JID Innov       Date:  2021-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.